ImageneBio (IMA) vs LeonaBio (LONA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
LeonaBio (LONA) has outperformed ImageneBio (IMA) over the past year, gaining 51.0% versus a loss of 44.7%. Over five years, LONA leads with a -93.9% price change compared with -96.8% for IMA. LeonaBio is the larger company by market cap ($54.0 million vs $47.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMA | LONA |
|---|---|---|
| Share price | $4.17 | $5.73 |
| Market cap | $47.43M | $53.99M |
| 1-day change | -9.54% | -1.72% |
| YTD return | -33.19% | -22.99% |
| 1-year return | -44.72% | +51.04% |
| 5-year return | -96.83% | -93.90% |
| EPS (TTM) | $-4.09 | $-23.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.10 | $14.21 |
| 52-week low | $3.94 | $2.21 |
| Distance from 52-week high | -54.18% | -59.68% |
| Average volume | 12.81K | 183.44K |
| Shares outstanding | 11.37M | 9.42M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LONA has outperformed IMA by 95.8 percentage points over the past year.
IMA vs LONA FAQ
Which is bigger, ImageneBio or LeonaBio?
LeonaBio (LONA) is larger, with a market capitalization of $53.99M compared with $47.43M for ImageneBio (IMA).
Which stock has performed better over the past year, IMA or LONA?
LONA returned +51.04% over the past 12 months, compared with -44.72% for IMA (price return, excluding dividends). Past performance does not predict future results.
Are ImageneBio and LeonaBio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.